Chronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical features

Mast cell leukemia (MCL) is a rare form of systemic mastocytosis characterized by leukemic expansion of mostly immature mast cells, organ damage, drug-resistance, and a poor prognosis. Even when treated with chemotherapy, most patients have a life-expectancy of less than one year. However, there are...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Valent, Peter (VerfasserIn) , Reiter, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: January 2015
In: Leukemia research
Year: 2015, Jahrgang: 39, Heft: 1, Pages: 1-5
ISSN:1873-5835
DOI:10.1016/j.leukres.2014.09.010
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.leukres.2014.09.010
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0145212614002926
Volltext
Verfasserangaben:Peter Valent, Karl Sotlar, Wolfgang R. Sperr, Andreas Reiter, Michel Arock, Hans-Peter Horny
Beschreibung
Zusammenfassung:Mast cell leukemia (MCL) is a rare form of systemic mastocytosis characterized by leukemic expansion of mostly immature mast cells, organ damage, drug-resistance, and a poor prognosis. Even when treated with chemotherapy, most patients have a life-expectancy of less than one year. However, there are rare patients with MCL in whom the condition is less aggressive and does not cause organ damage within a short time. In these patients, mast cells exhibit a more mature morphology when compared to acute MCL. A recently proposed classification suggests that these cases are referred to as chronic MCL. In the present article, we discuss clinical, histopathological and morphological aspects of acute and chronic MCL.
Beschreibung:Gesehen am 30.08.2017
Beschreibung:Online Resource
ISSN:1873-5835
DOI:10.1016/j.leukres.2014.09.010